NİHAT DEMİRHAN DEMİRKIRAN, Safiye AKTAŞ, Pınar ERÇETİN, Ömer BEKÇİOĞLU, Melek AYDIN, Hasan HAVİTÇİOĞLU

Cadmium in bone cement induces necrosis and decreases the viability of residual osteosarcoma cells: A xenograft study

Objective: The aim of this study was to show whether local application of cadmium-impregnated bone cement can induce apoptosis and decrease the viability of residual osteosarcoma (OS) cells in nude mice. Methods: K7M2 tumorigenic OS cell line was cultivated in vitro. The xenograft tumor model was formed by subcutaneously adding the tumor cells to athymic nude mice. Tumor was formed within 1 month. Then, mice were randomly assigned to five groups, each containing seven nude mice: control (group 1), wide resection (group 2), intralesional resection (group 3), intralesional resection + bone cement (group 4), and intralesional resection + cadmium embedded in bone cement (group 5). Tumor resection with 1 cm surgical margins was performed in the wide resection group. In intralesional resection groups, tumor tissue was resected with positive margins aiming to leave 15 mm3 of macroscopic tumor tissue. In group 3, the defect was left empty; groups 4 and 5 received bone cements prepared with saline and cadmium solutions, respectively. After the resection, mice were observed for 15 days and sacrificed. Next, surgical resection sites were evaluated histopathologically in each group. Results: Recurrent tumor was formed in all mice in the wide resection group, and apparent progression of residual tumor was observed in groups 3 and 4. On the contrary, only a thin layer of residual tumor was observed around the bone cement in group 5. Histological evaluation revealed remarkable necrosis in group 5 and lowest viability compared to other groups. No systemic toxic effect related to cadmium was observed. Conclusion: Our data suggest that local application of cadmium in bone cement has a significant potential to increase tumor necrosis and decrease the viability of residual OS cells.

___

1. Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma. Curr Opin Pharmacol 2014; 16: 15-23. [Crossref]

2. Fox MG, Trotta BM. Osteosarcoma: Review of the various types with emphasis on recent advancements in imaging. Semin Musculoskelet Radiol 2013; 17: 123-36. [Crossref]

3. Ando K, Heymann MF, Stresing V, Mori K, Rédini F, Heymann D. Current therapeutic strategies and novel approaches in osteosarcoma. Cancers 2013; 5: 591-616. [Crossref]

4. Bertrand TE, Cruz A, Binitie O, Cheong D, Letson GD. Do surgical margins affect local recurrence and survival in extremity, nonmetastatic, high-grade osteosarcoma? Clin Orthop Relat Res 2016; 474: 677-83. [Crossref]

5. Loh AHP, Navid F, Wang C, et al. Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery. Ann Surg Oncol 2014; 21: 1948-55. [Crossref]

6. Hernigou PH, Thiery JP, Benoit J, et al. Methotrexate diffusion from acrylic cement. Local chemotherapy for bone tumours. J Bone Joint Surg Br 1989; 71: 804-11. [Crossref]

7. Kim HS, Park YB, Oh JH, Yoo KH, Lee SH. The cytotoxic effect of methotrexate loaded bone cement on osteosarcoma cell lines. Int Orthop 2001; 25: 343-8. [Crossref]

8. Mestiri M, Benoit JP, Hernigou P, Devissaguet JP, Puisieux F. Cisplatin-loaded poly (methyl methacrylate) implants: a sustained drug delivery system. J Control Release 1995; 33: 107-13. [Crossref]

9. Özben H, Eralp L, Baysal G, Cort A, Sarkalkan N, Özben T. Cisplatin loaded PMMA: mechanical properties, surface analysis and effects on Saos-2 cell culture. Acta Orthop Traumatol Turc 2013; 47: 184-92. [Crossref]

10. Chen P, Duan X, Li M, et al. Systematic network assessment of the carcinogenic activities of cadmium. Toxicol Appl Pharmacol 2016; 310: 150-8. [Crossref]

11. Rahimzadeh MR, Rahimzadeh MR, Kazemi S, Moghadamnia AA. Cadmium toxicity and treatment: An update. Caspian J Intern Med 2017; 8: 135-45.

12. Staessen JA, Roels HA, Emelianov D, et al. Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Lancet 1999; 353: 1140-4. [Crossref]

13. Hu KH, Li WX, Sun MY, et al. Cadmium induced apoptosis in MG63 cells by increasing ROS, activation of p38 MAPK and inhibition of ERK 1/2 pathways. Cell Physiol Biochem 2015; 36: 642-54. [Crossref]

14. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152: 3-13. [Crossref]

15. Messerschmitt PJ, Garcia RM, Abdul-Karim FW, Greenfield EM, Getty PJ. Osteosarcoma. J Am Acad Orthop Surg 2009; 17: 515-27. [Crossref]

16. Zamborsky R, Kokavec M, Harsanyi S, Danisovic L. Identification of prognostic and predictive osteosarcoma biomarkers. Med Sci 2019; 7: 28. doi: 10.3390/medsci7020028. [Crossref]

17. Hong AM, Millington S, Ahern V, et al. Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: the oncological outcomes of 101 patients. Ann Oncol 2013; 24: 2676-80. [Crossref]

18. O’Kane GM, Cadoo KA, Walsh EM, et al. Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review. Clin Sarcoma Res 2015; 5: 17. doi: 10.1186/ s13569-015-0032-0. eCollection 2015. [Crossref]

19. Yu X, Wu S, Wang X, Xu M, Xu S, Yuan Y. Late post-operative recurrent osteosarcoma: Three case reports with a review of the literature. Oncol Lett 2013; 6: 23-7. [Crossref]

20. Bacci G, Ferrari S, Longhi A, et al. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. J Chemother 2001; 13: 93-9. [Crossref]

21. Angle CR, Thomas DJ, Swanson SA. Toxicity of cadmium to rat osteosarcoma cells (ROS 172.8): Protective effect of 1α, 25-dihydroxyvitamin D3. Toxicol Appl Pharmacol 1990; 103: 113- 20. [Crossref]

22. Long GJ. Cadmium perturbs calcium homeostasis in rat osteosarcoma (ROS 17/2.8) cells; a possible role for protein kinase C. Toxicol Lett 1997; 91: 91-7. [Crossref]

23. Thevenod F, Jones SW. Cadmium block of calcium current in frog sympathetic neurons. Biophys J 1992; 63: 162-8. [Crossref]

24. Przelecka A, Kluska AM, Zwierzyk M. Replacement of calcium by cadmium ions from Ca-affinity sites localized in different cytoplasmic compartments of Acanthamoeba cells. Histochemistry 1991; 95: 391-5. [Crossref]

25. Bhattacharyya MH, Whelton BD, Stern PH, Peterson DP. Cadmium accelerates bone loss in ovariectomized mice and fetal rat limb bones in culture. Proc Natl Acad Sci U S A 1988; 85: 8761-5. [Crossref]

26. Miyahara T, Miyakoshi M, Saito Y, Kozuka H. Influence of poisonous metals on bone metabolism: III. The effect of cadmium on bone resorption in tissue culture. Toxicol Appl Pharmacol 1980; 55: 477-83. [Crossref]

27. Kaji T, Kawatani R, Takata M, et al. The effects of cadmium, copper or zinc on formation of embryonic chick bone in tissue culture. Toxicology 1988; 50: 303-16. [Crossref]

28. Long GJ. The effect of cadmium on cytosolic free calcium, protein kinase C, and collagen synthesis in rat osteosarcoma (ROS 17/2.8) cells. Toxicol Appl Pharmacol 1997; 143: 189-95. [Crossref]

29. Waalkes MP, Rehm S, Sass B, Konishi N, Ward JM. Chronic carcinogenic and toxic effects of a single subcutaneous dose of cadmium in the male Fischer rat. Environ Res 1991; 55: 40-50. [Crossref]

30. Bettencourt A, Almeida AJ. Poly (methyl methacrylate) particulate carriers in drug delivery. J Microencapsul 2012; 29: 353- 67. [Crossref]

31. Hapa O, Karakaşlı A, Demirkıran ND, Akdeniz O, Havitçioğlu H. Operative treatment of chondroblastoma: A study of 11 cases. Acta Orthop Belg 2016; 82: 68-71.

32. Pountos I, Giannoudis PV. Drug-eluting implants for the suppression of metastatic bone disease: Current insights. Expert Rev Med Devices 2018; 15: 301-11. [Crossref]

33. Liu BM, Li M, Yin BS, Zou JY, Zhang WG, Wang SY. Effects of incorporating carboxymethyl chitosan into pmma bone cement containing methotrexate. PloS One 2015; 10: e0144407. doi: 10.1371/journal.pone.0144407. eCollection 2015. [Crossref]

34. Fröschle GW, Mählitz J, Langendorff HU, Achilles E, Pollock J, Jungbluth KH. Release of daunorubicin from polymethylmethacrylate for the improvement of the local growth control of bone metastasis animal experiments. Anticancer Res 1997; 17: 995-1002.

35. Demirkiran ND, Ercetin PA, Aydın M, Bekcioglu Ö, Havitcioglu H, Aktas S. In vitro application of cadmium within bone cement in osteosarcoma. Acta Oncol Turc 2020; 53: 166-72. [Crossref]